OXLUMO
Google image searchProduct monograph
Active ingredient
lumasiran (lumasiran sodium), 94.5 MG/0.5 ML
DIN: 02525755
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: ALNYLAM NETHERLANDS B.V.
Date: 05-MAY-2022
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AX — Various alimentary tract and metabolism products (ATC, ATC/DDD)
- A16AX18 — LUMASIRAN (ATC/DDD)
Reference brand drug: Oxlumo
